Concepedia

Jonathan Oh

JO

Statistics

Publications

4

Citations

421

H-Index

4

Active since

2011

Affiliations

Mary Crowley Cancer Research Center(Current)

Gradalis (United States)

Texas Oncology

Cancer Care Northwest

Medical City Dallas Hospital

Jonathan Oh is an author at Mary Crowley Cancer Research Center specializing in oncology, medicine, and immunotherapy.

Publications per year

2011–2020

4

Publications

4

Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer

Neil Senzer, Minal Barve, Joseph A. Kuhn et al. · Molecular Therapy · 2011 · 195 citations · Full text

, , +17

Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial

Rodney P. Rocconi, Elizabeth A. Grosen, Sharad Ghamande et al. · The Lancet Oncology · 2020 · 115 citations

, , +12

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Jonathan Oh, Minal Barve, Carolyn M. Matthews et al. · Gynecologic Oncology · 2016 · 90 citations

, , +16

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

Jonathan Oh, Minal Barve, Neil Senzer et al. · Gynecologic Oncology Reports · 2020 · 21 citations · Full text

, , +11

1–4 of 4